Fig. 2From: Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AITReactivity of different antibody subclasses against birch pollen proteins and therapy-related changes. Immunoblot experiments with birch pollen extract and sera of birch pollen AIT patients (P1–5) collected at three time points of immunotherapy (T0, T1, and T2). Bet v 1 is framed in black; NA, non-allergic serum; NBA, non-birch allergic serum; BC, buffer controlBack to article page